Bismuth-213 for Targeted Radionuclide Therapy: From Atom to Bedside

• Main Authors: Stephen Ahenkorah (Author), Irwin Cassells (Author), Christophe M. Deroose (Author), Thomas Cardinaels (Author), Andrew R. Burgoyne (Author), Guy Bormans (Author), Maarten Ooms (Author), Frederik Cleeren (Author)
• Format: Book
• Published: MDPI AG, 2021-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

In contrast to external high energy photon or proton therapy, targeted radionuclide therapy (TRNT) is a systemic cancer treatment allowing targeted irradiation of a primary tumor and all its metastases, resulting in less collateral damage to normal tissues. The α-emitting radionuclide bismuth-213 (&...